Another COVID vaccine option? Here’s what we know about the Novavax shot that’s on the way

The Phase 3 trial results showed Novavax was 90.4% effective overall, 93% effective against predominately circulating variants and 100% effective in preventing hospitalization and deaths.


You can find the complete original obituary on this website.

Obituariues recently published

Leave a Reply

Your email address will not be published.

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.